Travere Therapeutics’s (17R) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting Travere Therapeutics is a Buy.
Travere Therapeutics’s (17R) 20-Day exponential moving average is EUR 33.00, while Travere Therapeutics’s (17R) share price is EUR 33.00, making it a Buy.
Travere Therapeutics’s (17R) 50-Day exponential moving average is EUR 33.00, while Travere Therapeutics’s (17R) share price is EUR 33.00, making it a Buy.
Travere Therapeutics’s (17R) 10-Day exponential moving average is EUR 33.00, while Travere Therapeutics’s (17R) share price is EUR 33.00, making it a Buy.
Travere Therapeutics’s (17R) 100-Day exponential moving average is EUR 32.96, while Travere Therapeutics’s (17R) share price is EUR 33.00, making it a Buy.
Travere Therapeutics’s (17R) stock price is EUR 33.00 and Travere Therapeutics’s (17R) 50-day simple moving average is EUR 33.00, creating a Neutral signal.
Travere Therapeutics’s (17R) stock price is EUR 33.00 and Travere Therapeutics’s (17R) 100-day simple moving average is EUR 33.00, creating a Sell signal.
Travere Therapeutics’s (17R) stock price is EUR 33.00 and Travere Therapeutics’s (17R) 200-day simple moving average is EUR 33.00, creating a Neutral signal.
Travere Therapeutics (17R) Technical Indicators
1 Day timeframe · Data as of Nov 10, 2026
17R technical indicators
Name
Value
Implied Action
RSI (14)
63.30
Neutral
STOCH (9,6)
100.00
Sell
STOCHRSI (14)
100.00
Sell
MACD (12,26)
<0.01
Buy
ADX (14)
59.84
Sell
ATR (14)
0.20
-
Ultimate Oscillator
100.00
Buy
Bull/Bear Power (13)
-0.20
Sell
Travere Therapeutics’s (17R) Relative Strength Index (RSI) is 63.30, creating a Neutral signal.
Travere Therapeutics’s (17R) Trend Strength Indicator (ADX) is 59.84, creating a Sell signal.